Search Results 251-260 of 16940 for Adipokine
The purpose of this study is to evaluate the safety, tolerability, and preliminary effectiveness of HMPL-306 in advanced or metastatic solid tumors with IDH ...
This is a phase 2/3 open-label trial to evaluate the long-term safety, tolerability, and efficacy of sibeprenlimab administered subcutaneously (SC) in subjects ...
Subjects must not be eligible for therapy of higher curative potential where an alternative treatment has been shown to prolong survival in an analogous ...
Learn about this neurological condition that may affect an arm or a leg after an injury or surgery. Early treatment may prevent a recurrence.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
William Faubion is a dual certified specialist in pediatric and adult Gastroenterology with a focused interest in IBD, having nearly 20 years of experience in ...
After an up to 2 weeks screening period, eligible participants will be randomized in a 2:1 ratio to receive either efgartigimod IV or placebo IV, respectively ...
[MUSIC PLAYING]. Dan Childs, M.D., Oncologist: For a long time, we thought advanced prostate cancer was incurable. But now we see some men who have come in ...
The purpose of this study is to learn more about if the medication, Entresto, could help the function of the heart and kidneys. Participation eligibility.
Too little blood flow to the legs and arms can cause pain, especially during exercise. Learn more about diagnosing and treating intermittent claudication.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!